Scarica l'app Stockscreener
38.54
1.97%
0.69
Dopo l'orario di chiusura:
38.54
Precedente Chiudi:
$37.85
Aprire:
$38.98
Volume 24 ore:
554.51K
Relative Volume:
1.14
Capitalizzazione di mercato:
$1.91B
Reddito:
$3.18B
Utile/perdita netta:
$24.08M
Rapporto P/E:
84.50
EPS:
0.4561
Flusso di cassa netto:
$104.49M
1 W Prestazione:
-1.79%
1M Prestazione:
+14.46%
6M Prestazione:
+67.44%
1 anno Prestazione:
+58.90%
Intervallo 1D:
$38.08
$39.48
Intervallo di 1 settimana:
$36.95
$39.87
Portata 52W:
$18.08
$39.93
Astrana Health Inc Stock (ASTH) Company Profile
Nome
Astrana Health Inc
Settore
Industria
Telefono
(626) 282-0288
Indirizzo
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
38.54 | 1.88B | 3.18B | 24.08M | 104.49M | 0.4561 |
HCA
Hca Healthcare Inc
|
392.52 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
176.41 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.71 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.93 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | Needham | Buy |
| 2025-04-01 | Iniziato | Barclays | Equal Weight |
| 2024-10-14 | Iniziato | TD Cowen | Buy |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Aggiornamento | Truist | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-26 | Iniziato | Jefferies | Buy |
| 2024-02-22 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-24 | Iniziato | Stifel | Buy |
| 2023-12-22 | Iniziato | Truist | Hold |
| 2023-10-17 | Iniziato | BTIG Research | Buy |
| 2023-04-12 | Iniziato | BofA Securities | Neutral |
| 2022-12-19 | Iniziato | Lake Street | Buy |
| 2022-09-21 | Iniziato | William Blair | Outperform |
| 2022-01-11 | Ripresa | Colliers Securities | Buy |
| 2021-08-12 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Astrana Health Inc Borsa (ASTH) Ultime notizie
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - TradingView
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
Astrana Health Inc.Common Stock (NQ: ASTH - FinancialContent
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Australia
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations - Inkl
Astrana Health names George Christides interim medical director - Investing.com UK
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results - Yahoo Finance
Astrana Health announces appointment of interim national medical director - marketscreener.com
Astrana Health, Inc. Announces Appointment of Interim National Medical Director - PR Newswire
Astrana outlines $3.8B-$4.1B 2026 revenue outlook as net leverage targets at or below 2x - MSN
Astrana Health Announces Upcoming Chief Medical Officer Resignation - TipRanks
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 - Investing.com
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 By Investing.com - Investing.com South Africa
Astrana Health (NASDAQ: ASTH) CMO Dinesh Kumar plans June 1, 2026 exit - Stock Titan
Astrana Health (NASDAQ: ASTH) posts updated May 2026 investor presentation - Stock Titan
Astrana Health partners with California physician group - Investing.com UK
Astrana Health : Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care - marketscreener.com
Earnings call transcript: Astrana Health Q1 2026 Surpasses Expectations with Strong EPS and Revenue Growth - Investing.com Nigeria
Astrana Health partners with PAC to boost independent physicians via AI-driven Medicare ACO platform. - Pluang
Astrana Health Inc Azioni (ASTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Astrana Health Inc Azioni (ASTH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
1.89%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):